Abstract
Timely forecasting of dengue hospitalizations is essential for public health preparedness but is frequently limited by delays in official reporting systems. Climatic conditions strongly influence dengue transmission, yet hospitalization data often become available weeks after patient admission, reducing their value for early response. Digital information generated during clinical practice may provide a more timely signal of emerging disease activity.
This study evaluates whether integrating climate data with real-time records of physicians’ searches for dengue-related information improves short-term forecasts of dengue hospitalizations in Brazil under both ideal and realistic reporting conditions. Weekly hospitalization counts, weather indicators, and anonymized physician search data from a widely used clinical decision-support platform were combined to generate forecasts across multiple geographic regions. Model performance was compared under two scenarios: one assuming immediate availability of hospitalization data and another incorporating typical reporting delays.
When hospitalization data were timely, climate-based models achieved the highest predictive accuracy. Under realistic reporting delays, however, models incorporating physicians’ search behavior consistently outperformed approaches relying solely on climate information or hospitalization history. In several regions, increases in physician search activity preceded or coincided with rises in hospital admissions, indicating early clinical engagement with dengue cases.
These findings indicate that physician search behavior constitutes a valuable real-time indicator of dengue activity. Integrating digital clinical behavior with climate data enhances forecasting performance under real-world reporting constraints and may strengthen early-warning systems and public health decision-making for dengue and other climate-sensitive diseases.
Author Summary Dengue is a major public health challenge in Brazil, where large outbreaks place sudden pressure on health services. Although climate conditions influence dengue transmission, public health responses often rely on hospitalization data that become available only weeks or months after patients are admitted, limiting the ability to act early. In this study, we explored whether real-time digital information generated by physicians could help overcome this delay.
We combined weather data with anonymized records of physicians’ searches for dengue-related information within a widely used clinical decision-support platform in Brazil. We then tested whether these digital signals could improve short-term forecasts of dengue hospitalizations across different regions of the country, especially when official hospital data were delayed.
We found that climate patterns were strong predictors when hospitalization data were timely. However, under realistic reporting delays, models that incorporated physicians’ search behavior produced more accurate forecasts. These findings show that digital clinical behavior can provide early insight into rising disease activity and support more timely public health responses.
Competing Interest Statement
Dayanna de Oliveira Quintanilha Palmer, Eduardo C. Moura, Marcela Motta, Danielly Xavier, Ronaldo Gismondi, and Guilherme Schittine are employees or collaborators of Afya®, the company that owns the Afya Whitebook® platform evaluated in this study. Afya® had no role in the study design, data collection, data management, analysis, interpretation of results, manuscript preparation, or the decision to submit this article for publication. Dayanna de Oliveira Quintanilha Palmer also receives support from the 2025 Google PhD Fellowship in Health (Google Research), which likewise had no involvement in any stage of the research. Angélica Caseri declares no competing interests. The authors declare no additional competing interests.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research complies with the ethical principles established by Resolution CNS 466/12 of the Brazilian National Health Council. All data used were anonymized and derived from public or internal databases, with no individual-level identifiers or direct participant interaction. The research protocol was reviewed and approved by the Research Ethics Committee of the Centro Universitário Presidente Tancredo de Almeida Neves (UNIPTAN), under CAAE 81123624.4.0000.9667 and Opinion number 6.944.607. The Committee granted a waiver of informed consent given the exclusive use of anonymized secondary data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Hospitalization data from the Brazilian Hospital Information System (SIH/SUS) and meteorological data from the National Institute of Meteorology (INMET) are publicly available through the official portals listed in the references. Clinical-search data from the Afya Whitebook® platform contain proprietary and sensitive usage information and cannot be publicly released. These data can be made available upon reasonable request to the corresponding author, subject to approval by Afya®.
